
Bismuth Potassium Citrate by Zyntex is a high-purity pharmaceutical-grade compound (CAS 57644-54-9). It is a key Active Pharmaceutical Ingredient (API) used in quadruple therapy regimens to treat peptic ulcers and eradicate Helicobacter pylori through its combined antimicrobial and mucosal protective effects.
Enhanced solubility and efficacy provide a major advantage in clinical pharmacology. Bismuth Potassium Citrate works by precipitating in the acidic environment of the stomach, creating a thick protective film over ulcer sites. It helps patients recover from chronic gastritis and peptic lesions. For instance, it is a cornerstone ingredient in bismuth-containing quadruple therapy for the eradication of Helicobacter pylori. Consequently, it significantly improves the success rate of complex antibiotic treatments. As a result, Zyntex ensures high purity levels and strict adherence to international pharmaceutical standards for our supply. This ensures maximum stability and consistent dosage performance in your medicinal formulations.
Moreover, Zyntex supplies Bismuth Potassium Citrate for the production of advanced oral solid dosage forms. This compound acts as a reliable and stable source of bismuth ions in tablets and capsules. It pushes the boundaries of effective gastrointestinal therapy. At the same time, its chemical compatibility allows for the formulation of sophisticated combination therapies. In short, our product serves as a dependable “therapeutic stabilizer.” It supports both hospital-based clinical protocols and long-term outpatient digestive care.
Recently, scientific interest in Bismuth Potassium Citrate for its role in reducing gastric inflammation and its potential synergetic effects with proton pump inhibitors (PPIs) has grown. It provides a multi-faceted approach to digestive health. Because of this, Zyntex offers pharmaceutical grades with verified chemical profiles and low heavy-metal specifications. These formats suit modern generic drug development and large-scale manufacturing. Ultimately, choosing Zyntex secures a reliable and transparent pharmaceutical supply chain. We balance molecular expertise with rigorous batch-to-batch quality monitoring. To conclude, our commitment ensures your manufacturing processes achieve the highest levels of therapeutic reliability and regulatory compliance.
This high-purity pharmaceutical salt is vital in these four areas:
Key component in quadruple therapy regimens. Thus, it provides essential antimicrobial support to eliminate stubborn gut bacteria.
Primary API for treating gastric and duodenal ulcers. Consequently, it accelerates the healing of the stomach lining.
Used in the study of bismuth-based pharmaceutical delivery. Undoubtedly, it is a vital tool for advanced gastroenterology studies.
Essential building block for producing bioequivalent digestive treatments. Specifically, it supports the global supply of affordable medicine.
| Parameter | Standard Value |
|---|---|
| Product Name | Bismuth Potassium Citrate |
| Bismuth Content | 35.0% – 38.5% (Typical) |
| Appearance | White to off-white powder |
| CAS Number | 57644-54-9 |
📝 Storage Note: Store Bismuth Potassium Citrate in a cool, dry place within airtight and light-resistant containers. Therefore, protect the API from moisture and direct light to ensure its chemical stability and maintain therapeutic efficacy.